Reason for request
Re-assessment of Actual Benefit in compliance with article R. 163-21 of the French Social Security Code.
Clinical Benefit
| Insufficient |
The Committee considers that the actual benefit of AVANDIA and AVANDAMET products is now insufficient for it to be paid for by National Health Insurance, in comparison with existing therapies. |
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
ZXtzFHM7K8wwdCYU
